• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1012464-18
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Hemorrhage/Bleeding (1888); Perforation (2001); Renal Failure (2041); Respiratory Distress (2045); Swelling (2091)
Event Date 11/23/2017
Event Type  Death  
Manufacturer Narrative
The patient and device codes were coded by the manufacturer.(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The scaffold remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all relevant information.The other absorb device referenced is being filed under a separate medwatch report.The absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the u.S.
 
Event Description
It was reported that the patient presented with long term heart discomfort.The procedure in (b)(6) 2016 was to treat a lesion located in the left anterior descending (lad) artery.An unspecified absorb scaffold was implanted.After the procedure the patient recovered well with no adverse effects.On (b)(6) 2017 the patient reported heart discomfort and underwent a thallium (nuclear) scan.An inferior myocardial infarction was discovered.The patient was admitted for a percutaneous coronary intervention and a 3.5x18mm absorb scaffold was implanted for treatment.Post-dilatation was performed and a perforation occurred.The patient was transferred to another hospital and underwent a small operation to repair the perforation.There was no more bleeding but heart function was already severely damaged.The patient was placed on extracorporeal membrane oxygenation (ecmo) to survive.The next morning the patient's vital signs were critical due to severe hemopneumothorax of the right lung and intubation was performed.The patient's face was very swollen reportedly due to the perforation.The patient died on january 8, 2018 reportedly due to acute renal failure and multiple organ failure.No additional information was provided.
 
Manufacturer Narrative
(b)(4).There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A review of the lot history record of the reported device could not be conducted because the lot number was not provided.The reported patient effects of death, perforation and renal failure as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use are known adverse events associated with the use of a coronary scaffold in native coronary arteries.A conclusive cause for the reported patient effects and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key7334937
MDR Text Key102247742
Report Number2024168-2018-01766
Device Sequence Number1
Product Code PNY
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 03/29/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/13/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number1012464-18
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/27/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SCAFFOLD: UNK ABSORB; SCAFFOLD: UNK ABSORB; SCAFFOLD: UNK ABSORB
Patient Outcome(s) Death;
Patient Age66 YR
-
-